GINKGO BIOWORKS HOLDINGS, INC.
(DNA)Financial Statements · SEC EDGAR XBRL
Revenue
$170.2M
-25.1%
Net Income
-$313K
+42.8%
EPS
$-5.64
+46.5%
Op. Income
-$315.3M
+43.7%
FCF
-$178.7M
+53.2%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Operating Expenses & Income
Research & Development
Total Operating Expenses
Operating Income
Non-Operating Income/Expense
Interest Income/Expense
Other Non-Operating Income
Pre-Tax Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)